PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3641

  1. 1,502 Posts.
    lightbulb Created with Sketch. 191
    Thanks for sharing

    I really enjoyed that and things are progressing well

    I can’t stop thinking about those poor MPS sufferers and how brave they are to go on a placebo. How encouraging to hear that the drug will be made available for 5 years to those taking part in the trial

    Lots of news coming up in the next 3 to 4 months

    When will the investment community wake up to the opportunity to buy into a potential blockbuster of a compan
    We know it works for the majority of OA sufferers
    We can see the benefits for MPS patients
    The dogs are almost certainly going to benefit and we know how dog lovers will spend vast amounts on their loved pets. Heck my wife things more of her dogs than she does of me. Mind you I don’t blame her. No comments @poolboy

    I guess for some investors the time frame is still an issue. 2025 into 2026 is an issue for some in this get rich quick lottery world we live

    Buy more and bottom drawer for me and for my grandchildren



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.